• Advising and representing a global pharmaceutical company in enforcing its "Second Medical Use" patent for its neuropathic pain blockbuster
  • Advising a global pharmaceutical company on the experimental use privilege (Roche-Bolar exemption) in connection with Phase-III clinical trials on a novel bi-specific monoclonal antibody for the treatment of a hematologic disease
  • Advising and representing a global pharmaceutical company on a PD-1 inhibitor (monoclonal antibody) for the immunotherapy of cancers
  • Advising a leading scientist on licensing issues related to a recombinant pharmaceutical for the treatment of a hematologic disease
  • Advising and representing a global medical devices company in enforcing its patent on DNA amplification and sequencing
  • Advising and representing a global diagnostics company on an immunologic test for early detection of pre-eclampsia/HELLP-syndrome (gestosis)
  • Ongoing advice of a global pharmaceutical company on compliance, anti-corruption, cooperation with hospitals and physicians, clinical trials and professional codes of physicians